SPCA1 Antibodies

Santa Cruz Biotechnology provides a broad selection of SPCA1 monoclonal antibodies for research focused on secretory pathway calcium ATPase 1 (SPCA1). SPCA1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SPCA1 is crucial for maintaining calcium homeostasis and plays a significant role in cellular signaling and muscle contraction. Its function is vital in various physiological processes, and dysregulation of SPCA1 has been implicated in several diseases, making it an important target for research. Understanding SPCA1 mechanisms can provide insights into therapeutic strategies for conditions related to calcium signaling. Research has shown that SPCA1 expression levels vary across different tissue types, with particularly high expression in secretory cells and muscle tissue. Recent studies have highlighted SPCA1's involvement in neurodegenerative disorders and various cancers, emphasizing its significance in disease progression. Investigating SPCA1's role in calcium transport and cellular function continues to reveal new potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of SPCA1's role in health and disease.